Colorado board permits state to appeal injunction against arthritis drug price cap
A Colorado board voted Friday to allow the Attorney General’s Office to fight an injunction against a price…
TGA issues warning over GLP-1-based drugs’ potential to cause rare eye disorder
The medicines regulator has issued a new safety warning for GLP-1-based drugs, like Ozempic, which could potentially cause…
New FDA-approved cholesterol pill lowers bad LDL | Tap to know more | Inshorts – Inshorts
New FDA-approved cholesterol pill lowers bad LDL | Tap to know more | Inshorts InshortsWe’re beating heart disease vox.comNewly approved…
Deadline fast approaching for Canadians to file claim in class-action drug suit
The deadline is fast approaching for Canadians to claim their share of a multimillion-dollar class-action lawsuit over the…
Africa’s most developed pharmaceutical market reviews 12 Ozempic generics as drugmakers target Novo Nordisk’s dominance
The applications could bring more affordable versions of one of the world’s most sought-after medicines into one…
‘Life-Changing’ MS Drug Could Help Thousands Walk for Longer and Regain More Independence
Thousands of people with multiple sclerosis in England are set to gain access to a drug that could…
First-in-Class Drug for ADHD Wins FDA Approval
The FDA approved oral centanafadine (Simtriyo), a first-in-class triple reuptake inhibitor for attention deficit-hyperactivity disorder (ADHD), Otsuka announced…
Weight loss drugs reduce some employee sick time, a study finds
Savings to the overall health care economy from GLP-1 drugs have yet to be proven, but researchers have…
Federal survey shows promising youth mental health trends
A key U.S. government report on mental health, substance use and addiction showed continued improvements in several metrics,…
Canadians have 1 month left to file claim in class-action drug suit
Listen to this article Estimated 1 minute The audio version of this article is generated by AI-based technology.…
Deadline fast approaching for Canadians to file claim in class-action drug suit
MONTREAL — The deadline is fast approaching for Canadians to claim their share of a multimillion-dollar class-action lawsuit…
Deadline nears to file claim in class-action lawsuit over drug Rexulti
The deadline is fast approaching for Canadians to claim their share of a multimillion-dollar class-action lawsuit over the…